A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients (Q43060768)
Jump to navigation
Jump to search
scientific article published on 18 May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients |
scientific article published on 18 May 2010 |
Statements
1 reference
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients (English)
1 reference
Suzette Delaloge
1 reference
Philippe Bertheau
1 reference
Marc Espié
1 reference
Jean-Yves Pierga
1 reference
Etienne Brain
1 reference
Brigitte Sigal-Zafrani
1 reference
Marie-Christine Mathieu
1 reference
Jean Marc Guinebretière
1 reference
Marc Spielmann
1 reference
Alexia Savignoni
1 reference
Michel Marty
1 reference
18 May 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference